MRTN

MRTN Total Current Liabilities

$95.05MQuarterly · USD

Period ending:

MRTN FY Current LiabilitiesUSD
MRTN FY Current Liabilities1986-12-31: $7.30M1987-12-31: $13.30M1988-12-31: $15.50M1989-12-31: $20.30M1990-12-31: $21.00M1991-12-31: $20.90M1992-12-31: $24.80M1993-12-31: $30.80M1994-12-31: $33.81M1995-12-31: $40.35M1996-12-31: $44.68M1997-12-31: $46.31M1998-12-31: $31.21M1999-12-31: $32.81M2000-12-31: $23.99M2001-12-31: $27.16M2002-12-31: $32.16M2003-12-31: $34.66M2004-12-31: $38.37M2005-12-31: $45.78M2006-12-31: $59.42M2007-12-31: $54.82M2008-12-31: $57.52M2009-12-31: $54.22M2010-12-31: $68.59M2011-12-31: $46.39M2012-12-31: $46.90M2013-12-31: $53.03M2014-12-31: $44.52M2015-12-31: $49.88M2016-12-31: $60.67M2017-12-31: $64.28M2018-12-31: $71.97M2019-12-31: $76.33M2020-12-31: $89.79M2021-12-31: $93.56M2022-12-31: $124.31M2023-12-31: $110.24M2024-12-31: $93.52M2025-12-31: $92.23M$124.31M$0.00
1986-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

MRTN total current liabilities history

Liabilities due within one year. The available annual fiscal periods series contains 40 observations from Dec 31, 1986 to Dec 31, 2025.

Marten Transport Ltd Total Current Liabilities — Annual fiscal periods (USD)
Period endingTotal Current Liabilities (USD)
92,232,000
93,519,000
110,242,000
124,310,000
93,559,000
89,794,000
76,326,000
71,973,000
64,277,000
60,670,000
49,876,000
44,518,000
53,028,000
46,900,000
46,385,000
68,589,000
54,217,000
57,515,000
54,815,000
59,422,000
45,775,000
38,374,000
34,663,000
32,160,000
27,162,000
23,994,000
32,814,000
31,205,000
46,311,000
44,682,000
40,345,000
33,811,000
30,800,000
24,800,000
20,900,000
21,000,000
20,300,000
15,500,000
13,300,000
7,300,000

Compare total current liabilities

All MRTN financial metrics · MRTN stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.